BridgeMD
Compares treatment options for Depression
Official title Comparing Clinical Decision-making of AI Technology to a Multi-professional Care Team in ECBT for Depression
ClinicalTrials.gov ID: NCT05648175
What this study is testing
- What it's testing
- Depression is a leading cause of disability worldwide, affecting up to 300 million people globally. Despite its high prevalence and debilitating effects, only one-third of patients newly diagnosed with depression initiate treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosed with MDD by a trained research assistant according to the criteria outlined in the DSM-5
- Ability to provide informed consent
- Ability to speak and read English
- Having consistent and reliable access to the internet
You likely can't join if
- Active psychosis
- Acute mania
- Severe alcohol, or substance use disorder
- Active suicidal or homicidal ideation
- Currently receiving psychotherapy
The study team makes the final eligibility decision.
Where it's taking place
- Kingston, Ontario, Canada
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kingston, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.